Full history for every metric is available with a Kvantra account
Opyl Limited (OPL.AX)
Key financial summary
Financials in AUD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | AUD m | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating profit | AUD m | -3 | -3 | |||||
| Net profit | AUD m | -3 | -1 | -1 | -2 | -2 | -3 | -3 |
| EPS reported | AUD | -0.02 | -0.01 | |||||
| Operating cashflow per share | AUD | -0.01 | -0.01 | |||||
| Capex per share | AUD | 0.00 | 0.00 | |||||
| FCF per share | AUD | -0.01 | -0.01 | |||||
| Free cash flow | AUD m | -2 | -2 | |||||
| Net debt | AUD m | -0 | 0 | |||||
| Book value equity | AUD m | -0 | -0 | |||||
| Book value per share | AUD | -0.00 | -0.00 | |||||
| Number of shares | m | 170.72 | 170.8 | |||||
| DPS (TTM paid) | AUD | 0.00 | 0.00 |
Financial summary
Financials in AUD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -49.23 | -17.39 | |||||
| P/S LTM | x | 11.16 | 27.57 | |||||
| P/FCF LTM | x | -2.14 | -2.56 | |||||
| EV/EBITDA LTM | x | -1.52 | -2.23 | |||||
| EV/Sales LTM | x | 10.22 | 28.08 | |||||
| Earnings Yield LTM | % | -70.52% | -83.34% | |||||
| FCF Yield | % | -46.74% | -39.13% | |||||
| Quality | ||||||||
| ROE | % | 3471.6% | 1267.9% | |||||
| ROIC | % | 3063.9% | 3063.9% | |||||
| Operating margin | % | -811.29% | -811.29% | |||||
| Gross margin | % | -351.83% | -351.83% | |||||
| FCF/Sales | % | -521.68% | -521.68% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -35.65% | -67.78% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | -4.94 | |||||
| Net Debt/EBITDA | x | 0.14 | 0.14 | |||||
| EBIT/Net interest | x | -7.56 | -7.56 | |||||
| Net debt/market cap | % | -8.44% | 1.83% | |||||
| Net debt/Equity | x | 4.16 | -0.32 | |||||
| Gross debt/equity | x | -0.00 | -1.38 | |||||
Company overview
Based in St Kilda, Australia, Opyl Limited, originally incorporated in 1994 as ShareRoot Limited before its rebranding in December 2019, specializes in developing digital innovations that significantly improve the healthcare journey for Australian patients. The company also offers valuable market intelligence gleaned from social media data and works to optimize clinical research procedures. Among its key offerings is Opin, an advanced platform for recruiting participants into clinical trials, which effectively connects patients with appropriate studies by utilizing social media, search engine optimization, and artificial intelligence. Additionally, Opyl provides comprehensive social media marketing agency services, including client and account management, specifically catering to the pharmaceutical, medical technology, and biotechnology industries.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Opyl Limited (OPL.AX)
Based in St Kilda, Australia, Opyl Limited, originally incorporated in 1994 as ShareRoot Limited before its rebranding in December 2019, specializes in developing digital innovations that significantly improve the healthcare journey for Australian patients. The company also offers valuable market intelligence gleaned from social media data and works to optimize clinical research procedures. Among its key offerings is Opin, an advanced platform for recruiting participants into clinical trials, which effectively connects patients with appropriate studies by utilizing social media, search engine optimization, and artificial intelligence. Additionally, Opyl provides comprehensive social media marketing agency services, including client and account management, specifically catering to the pharmaceutical, medical technology, and biotechnology industries.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free